Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

05-04-2023 | Glaucoma | Mini Review

Quality of life in glaucoma

Authors: Kareem Latif, Takashi Nishida, Sasan Moghimi, Robert N. Weinreb

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 10/2023

Abstract

Background

An essential goal of glaucoma management is to prevent a patient’s visual impairment that compromises their health-related quality of life (QOL). The disease itself, in addition to the medical or surgical treatment, can have a large impact on one’s life. We aim to briefly review and evaluate aspects of QOL in glaucoma.

Methods

The PubMed database was utilized for the literature examination of this review. Keywords that were searched included glaucoma, quality of life, vision-related QOL (VRQOL), quality of life questionnaire, and glaucoma therapy.

Results

The main topics identified and analyzed during the literature review stages include factors affecting VRQOL, the assessment of VRQOL using questionnaires, QOL in early and severe glaucoma, glaucoma and activities of daily living, glaucoma treatments, and new advances in clinically assessing QOL. The study findings indicate a relationship between the deterioration of visual field and the quality of life. The investigation shows that visual loss can result in a range of daily life challenges, which include compromised mental health status and difficulties with driving, reading, and recognizing people.

Conclusion

Glaucoma-induced visual field loss can significantly impact different aspects of patients’ life, and several methods exist for evaluating changes in quality of life. Quality of life assessments have their limitations as they are subjective. As potential future steps, we suggest exploring technological advancements such as virtual reality to improve patient care and outcomes.

Weinreb RN, Leung CK, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, Martin KR (2016) Primary open-angle glaucoma. Nat Rev Dis Primers 2:16067. https://doi.org/10.1038/nrdp.2016.67CrossRefPubMed

Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311:1901–1911. https://doi.org/10.1001/jama.2014.3192CrossRefPubMedPubMedCentral

Blindness GBD, Vision Impairment C, Vision Loss Expert Group of the Global Burden of Disease S (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health 9:e144–e160. https://doi.org/10.1016/S2214-109X(20)30489-7CrossRef

Medeiros FA, Lisboa R, Zangwill LM, Liebmann JM, Girkin CA, Bowd C, Weinreb RN (2014) Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma. Ophthalmology 121:100–109. https://doi.org/10.1016/j.ophtha.2013.06.026CrossRefPubMed

(1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 28: 551–558 https://doi.org/10.1017/s0033291798006667

Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, National Eye Institute Visual Function Questionnaire Field Test I (2001) Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119:1050–1058. https://doi.org/10.1001/archopht.119.7.1050CrossRefPubMed

Richman J, Lorenzana LL, Lankaranian D, Dugar J, Mayer JR, Wizov SS, Spaeth GL (2010) Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol 17:144–151. https://doi.org/10.3109/09286581003734878CrossRefPubMed

Chiang MF (2021) The 2021 National Eye Institute strategic plan-relating vision to health and quality of life. JAMA Ophthalmol 139:1263–1265. https://doi.org/10.1001/jamaophthalmol.2021.4774CrossRefPubMed

Nirmalan PK, Tielsch JM, Katz J, Thulasiraj RD, Krishnadas R, Ramakrishnan R, Robin AL (2005) Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 46:2308–2312. https://doi.org/10.1167/iovs.04-0830CrossRefPubMed

10.

Broman AT, Munoz B, Rodriguez J, Sanchez R, Quigley HA, Klein R, Snyder R, West SK (2002) The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci 43:3393–3398PubMed

11.

Knudtson MD, Klein BE, Klein R, Cruickshanks KJ, Lee KE (2005) Age-related eye disease, quality of life, and functional activity. Arch Ophthalmol 123:807–814. https://doi.org/10.1001/archopht.123.6.807CrossRefPubMed

12.

Nutheti R, Shamanna BR, Nirmalan PK, Keeffe JE, Krishnaiah S, Rao GN, Thomas R (2006) Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest Ophthalmol Vis Sci 47:4742–4748. https://doi.org/10.1167/iovs.06-0020CrossRefPubMed

13.

Wu SY, Hennis A, Nemesure B, Leske MC, Barbados Eye Studies G (2008) Impact of glaucoma, lens opacities, and cataract surgery on visual functioning and related quality of life: the Barbados eye studies. Invest Ophthalmol Vis Sci 49:1333–1338. https://doi.org/10.1167/iovs.07-1252CrossRefPubMed

14.

Gedde SJ, Vinod K, Wright MM, Muir KW, Lind JT, Chen PP, Li T, Mansberger SL, American Academy of Ophthalmology Preferred Practice Pattern Glaucoma P (2021) Primary open-angle glaucoma preferred practice pattern(R). Ophthalmology 128:P71–P150. https://doi.org/10.1016/j.ophtha.2020.10.022CrossRefPubMed

15.

Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS (2009) Glaucoma and reading speed: the Salisbury eye evaluation project. Arch Ophthalmol 127:82–87. https://doi.org/10.1001/archophthalmol.2008.523CrossRefPubMedPubMedCentral

16.

Friedman DS, Freeman E, Munoz B, Jampel HD, West SK (2007) Glaucoma and mobility performance: the Salisbury eye evaluation project. Ophthalmology 114:2232–2237. https://doi.org/10.1016/j.ophtha.2007.02.001CrossRefPubMed

17.

Freeman EE, Munoz B, West SK, Jampel HD, Friedman DS (2008) Glaucoma and quality of life: the Salisbury eye evaluation. Ophthalmology 115:233–238. https://doi.org/10.1016/j.ophtha.2007.04.050CrossRefPubMed

18.

McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R (2008) Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino eye study. Ophthalmology 115:941-948.e941. https://doi.org/10.1016/j.ophtha.2007.08.037CrossRefPubMed

19.

Medeiros FA, Gracitelli CP, Boer ER, Weinreb RN, Zangwill LM, Rosen PN (2015) Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology 122:293–301. https://doi.org/10.1016/j.ophtha.2014.08.014CrossRefPubMed

20.

van Gestel A, Webers CA, Beckers HJ, van Dongen MC, Severens JL, Hendrikse F, Schouten JS (2010) The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond) 24:1759–1769. https://doi.org/10.1038/eye.2010.133CrossRefPubMed

21.

Arora KS, Boland MV, Friedman DS, Jefferys JL, West SK, Ramulu PY (2013) The relationship between better-eye and integrated visual field mean deviation and visual disability. Ophthalmology 120:2476–2484. https://doi.org/10.1016/j.ophtha.2013.07.020CrossRefPubMed

22.

Man REK, Gan ATL, Fenwick EK, Gupta P, Thakur S, Fang XL, Cheng CY, Wong TY, Lamoureux EL (2021) The differential impact of age on vision-related quality of life across the visual impairment spectrum. Ophthalmology 128:354–363. https://doi.org/10.1016/j.ophtha.2020.07.046CrossRefPubMed

23.

Grisafe DJ, 2nd, McKean-Cowdin R, Burkemper BS, Xu BY, Torres M, Varma R, Multiethnic Ophthalmology Cohorts of California Study G (2022) Visual field loss impacts vision-specific quality of life by race and ethnicity: the multiethnic ophthalmology cohorts of California study. Ophthalmology 129: 668-678.https://doi.org/10.1016/j.ophtha.2022.01.001

24.

Sawada H, Yoshino T, Fukuchi T, Abe H (2014) Assessment of the vision-specific quality of life using clustered visual field in glaucoma patients. J Glaucoma 23:81–87. https://doi.org/10.1097/IJG.0b013e318265bbdcCrossRefPubMed

25.

Abe RY, Diniz-Filho A, Costa VP, Gracitelli CP, Baig S, Medeiros FA (2016) The impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma. Ophthalmology 123:552–557. https://doi.org/10.1016/j.ophtha.2015.10.046CrossRefPubMed

26.

Cheng HC, Guo CY, Chen MJ, Ko YC, Huang N, Liu CJ (2015) Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol 133:269–275. https://doi.org/10.1001/jamaophthalmol.2014.4908CrossRefPubMed

27.

Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, Lee PP (1998) Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116:227–233. https://doi.org/10.1001/archopht.116.2.227CrossRefPubMed

28.

Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 116:1496–1504. https://doi.org/10.1001/archopht.116.11.1496CrossRefPubMed

29.

Gutierrez P, Wilson MR, Johnson C, Gordon M, Cioffi GA, Ritch R, Sherwood M, Meng K, Mangione CM (1997) Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 115:777–784. https://doi.org/10.1001/archopht.1997.01100150779014CrossRefPubMed

30.

Lee BL, Gutierrez P, Gordon M, Wilson MR, Cioffi GA, Ritch R, Sherwood M, Mangione CM (1998) The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol 116:861–866. https://doi.org/10.1001/archopht.116.7.861CrossRefPubMed

31.

Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD, Legro MW, Diener-West M, Bass EB, Damiano AM et al (1994) The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 112:630–638. https://doi.org/10.1001/archopht.1994.01090170074026CrossRefPubMed

32.

Damiano AM, Steinberg EP, Cassard SD, Bass EB, Diener-West M, Legro MW, Tielsch J, Schein OD, Javitt J, Kolb M (1995) Comparison of generic versus disease-specific measures of functional impairment in patients with cataract. Med Care 33:AS120-130PubMed

33.

Cassard SD, Patrick DL, Damiano AM, Legro MW, Tielsch JM, Diener-West M, Schein OD, Javitt JC, Bass EB, Steinberg EP (1995) Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Arch Ophthalmol 113:1508–1513. https://doi.org/10.1001/archopht.1995.01100120038005CrossRefPubMed

34.

Parrish RK 2nd, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, Mangione CM, Montenegro-Piniella A (1997) Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 115:1447–1455. https://doi.org/10.1001/archopht.1997.01100160617016CrossRefPubMed

35.

Sherwood MB, Garcia-Siekavizza A, Meltzer MI, Hebert A, Burns AF, McGorray S (1998) Glaucoma’s impact on quality of life and its relation to clinical indicators. Pilot Study Ophthalmols 105:561–566. https://doi.org/10.1016/S0161-6420(98)93043-3CrossRef

36.

Alqudah A, Mansberger SL, Gardiner SK, Demirel S (2016) Vision-related quality of life in glaucoma suspect or early glaucoma patients. J Glaucoma 25:629–633. https://doi.org/10.1097/IJG.0000000000000445CrossRefPubMedPubMedCentral

37.

Prager AJ, Hood DC, Liebmann JM, De Moraes CG, Al-Aswad LA, Yu Q, Cioffi GA, Blumberg DM (2017) Association of glaucoma-related, optical coherence tomography-measured macular damage with vision-related quality of life. JAMA Ophthalmol 135:783–788. https://doi.org/10.1001/jamaophthalmol.2017.1659CrossRefPubMedPubMedCentral

38.

Shabana N, Cornilleau-Peres V, Droulez J, Goh JC, Lee GS, Chew PT (2005) Postural stability in primary open angle glaucoma. Clin Exp Ophthalmol 33:264–273. https://doi.org/10.1111/j.1442-9071.2005.01003.xCrossRefPubMed

39.

Mihailovic A, Swenor BK, Friedman DS, West SK, Gitlin LN, Ramulu PY (2017) Gait implications of visual field damage from glaucoma. Transl Vis Sci Technol 6:23. https://doi.org/10.1167/tvst.6.3.23CrossRefPubMedPubMedCentral

40.

Turano KA, Rubin GS, Quigley HA (1999) Mobility performance in glaucoma. Invest Ophthalmol Vis Sci 40:2803–2809PubMed

41.

Sotimehin AE, Yonge AV, Mihailovic A, West SK, Friedman DS, Gitlin LN, Ramulu PY (2018) Locations, circumstances, and outcomes of falls in patients with glaucoma. Am J Ophthalmol 192:131–141. https://doi.org/10.1016/j.ajo.2018.04.024CrossRefPubMedPubMedCentral

42.

Kwon M, Huisingh C, Rhodes LA, McGwin G Jr, Wood JM, Owsley C (2016) Association between glaucoma and at-fault motor vehicle collision involvement among older drivers: a population-based study. Ophthalmology 123:109–116. https://doi.org/10.1016/j.ophtha.2015.08.043CrossRefPubMed

43.

van Landingham SW, Hochberg C, Massof RW, Chan E, Friedman DS, Ramulu PY (2013) Driving patterns in older adults with glaucoma. BMC Ophthalmol 13:4. https://doi.org/10.1186/1471-2415-13-4CrossRefPubMedPubMedCentral

44.

Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C (2003) Quality of life in glaucoma and its relationship with visual function. J Glaucoma 12:139–150. https://doi.org/10.1097/00061198-200304000-00009CrossRefPubMed

45.

Bhargava JS, Patel B, Foss AJ, Avery AJ, King AJ (2006) Views of glaucoma patients on aspects of their treatment: an assessment of patient preference by conjoint analysis. Invest Ophthalmol Vis Sci 47:2885–2888. https://doi.org/10.1167/iovs.05-1244CrossRefPubMed

46.

McGwin G Jr, Mays A, Joiner W, Decarlo DK, McNeal S, Owsley C (2004) Is glaucoma associated with motor vehicle collision involvement and driving avoidance? Invest Ophthalmol Vis Sci 45:3934–3939. https://doi.org/10.1167/iovs.04-0524CrossRefPubMed

47.

Haymes SA, Leblanc RP, Nicolela MT, Chiasson LA, Chauhan BC (2007) Risk of falls and motor vehicle collisions in glaucoma. Invest Ophthalmol Vis Sci 48:1149–1155. https://doi.org/10.1167/iovs.06-0886CrossRefPubMed

48.

Hu PS, Trumble DA, Foley DJ, Eberhard JW, Wallace RB (1998) Crash risks of older drivers: a panel data analysis. Accid Anal Prev 30:569–581. https://doi.org/10.1016/s0001-4575(98)00019-0CrossRefPubMed

49.

Tanabe S, Yuki K, Ozeki N, Shiba D, Abe T, Kouyama K, Tsubota K (2011) The association between primary open-angle glaucoma and motor vehicle collisions. Invest Ophthalmol Vis Sci 52:4177–4181. https://doi.org/10.1167/iovs.10-6264CrossRefPubMed

50.

Nguyen AM, van Landingham SW, Massof RW, Rubin GS, Ramulu PY (2014) Reading ability and reading engagement in older adults with glaucoma. Invest Ophthalmol Vis Sci 55:5284–5290. https://doi.org/10.1167/iovs.14-14138CrossRefPubMedPubMedCentral

51.

Burton R, Saunders LJ, Crabb DP (2015) Areas of the visual field important during reading in patients with glaucoma. Jpn J Ophthalmol 59:94–102. https://doi.org/10.1007/s10384-014-0359-8CrossRefPubMed

52.

Glen FC, Crabb DP, Smith ND, Burton R, Garway-Heath DF (2012) Do patients with glaucoma have difficulty recognizing faces? Invest Ophthalmol Vis Sci 53:3629–3637. https://doi.org/10.1167/iovs.11-8538CrossRefPubMed

53.

Skalicky S, Goldberg I (2008) Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma 17:546–551. https://doi.org/10.1097/IJG.0b013e318163bdd1CrossRefPubMed

54.

Zhang X, Olson DJ, Le P, Lin FC, Fleischman D, Davis RM (2017) The association between glaucoma, anxiety, and depression in a large population. Am J Ophthalmol 183:37–41. https://doi.org/10.1016/j.ajo.2017.07.021CrossRefPubMed

55.

Hugues FC, Le Jeunne C (1993) Systemic and local tolerability of ophthalmic drug formulations. An update Drug Saf 8:365–380. https://doi.org/10.2165/00002018-199308050-00004CrossRefPubMed

56.

Guldvog B (1999) Can patient satisfaction improve health among patients with angina pectoris? Int J Qual Health Care 11:233–240. https://doi.org/10.1093/intqhc/11.3.233CrossRefPubMed

57.

Donabedian A (1988) The quality of care. How can it be assessed? JAMA 260:1743–1748. https://doi.org/10.1001/jama.260.12.1743CrossRefPubMed

58.

Marquis MS, Davies AR, Ware JE Jr (1983) Patient satisfaction and change in medical care provider: a longitudinal study. Med Care 21:821–829. https://doi.org/10.1097/00005650-198308000-00006CrossRefPubMed

59.

Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW (2003) Compliance barriers in glaucoma: a systematic classification. J Glaucoma 12:393–398. https://doi.org/10.1097/00061198-200310000-00001CrossRefPubMed

60.

Jampel HD, Schwartz GF, Robin AL, Abrams DA, Johnson E, Miller RB (2003) Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol 121:540–546. https://doi.org/10.1001/archopht.121.4.540CrossRefPubMed

61.

Balkrishnan R, Bond JB, Byerly WG, Camacho FT, Anderson RT (2003) Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization. Am J Geriatr Pharmacother 1:75–81. https://doi.org/10.1016/s1543-5946(03)90003-1CrossRefPubMed

62.

Naito T, Namiguchi K, Yoshikawa K, Miyamoto K, Mizoue S, Kawashima Y, Shiraishi A, Shiraga F (2017) Factors affecting eye drop instillation in glaucoma patients with visual field defect. PLoS One 12:e0185874. https://doi.org/10.1371/journal.pone.0185874CrossRefPubMedPubMedCentral

63.

Guedes RA, Guedes VM, Freitas SM, Chaoubah A (2013) Quality of life of medically versus surgically treated glaucoma patients. J Glaucoma 22:369–373. https://doi.org/10.1097/IJG.0b013e31824ceb8bCrossRefPubMed

64.

Katz LJ, Erb C, Carceller GA, Fea AM, Voskanyan L, Wells JM, Giamporcaro JE (2015) Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol 9:2313–2320. https://doi.org/10.2147/OPTH.S96695CrossRefPubMedPubMedCentral

65.

Perez-Torregrosa VT, Olate-Perez A, Cerda-Ibanez M, Gargallo-Benedicto A, Osorio-Alayo V, Barreiro-Rego A, Duch-Samper A (2016) Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Arch Soc Esp Oftalmol 91:415–421. https://doi.org/10.1016/j.oftal.2016.02.006CrossRefPubMed

66.

Samuelson TW, Singh IP, Williamson BK, Falvey H, Lee WC, Odom D, McSorley D, Katz LJ (2021) Quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject(R) pivotal trial. Am J Ophthalmol 229:220–229. https://doi.org/10.1016/j.ajo.2021.03.007CrossRefPubMed

67.

Lam AKN, To E, Weinreb RN, Yu M, Mak H, Lai G, Chiu V, Wu K, Zhang X, Cheng TPH, Guo PY, Leung CKS (2020) Use of virtual reality simulation to identify vision-related disability in patients with glaucoma. JAMA Ophthalmol 138:490–498. https://doi.org/10.1001/jamaophthalmol.2020.0392CrossRefPubMedPubMedCentral

68.

Bennett CR, Bex PJ, Bauer CM, Merabet LB (2019) The assessment of visual function and functional vision. Semin Pediatr Neurol 31:30–40. https://doi.org/10.1016/j.spen.2019.05.006CrossRefPubMedPubMedCentral

69.

Colenbrander A (2005) Visual functions and functional vision International Congress Series. Elsevier, 482–486

70.

Fenwick EK, Roldan AM, Halawa OA, Meshkin RS, Zebardast N, Popov V, Lis P, Friedman DS, Lamoureux EL (2022) Implementation of an online glaucoma-specific quality of life computerized adaptive test system in a US Glaucoma Hospital. Transl Vis Sci Technol 11:24. https://doi.org/10.1167/tvst.11.2.24CrossRefPubMedPubMedCentral

71.

Waisbourd M, Parker S, Ekici F, Martinez P, Murphy R, Scully K, Wizov SS, Hark LA, Spaeth GL (2015) A prospective, longitudinal, observational cohort study examining how glaucoma affects quality of life and visually-related function over 4 years: design and methodology. BMC Ophthalmol 15:91. https://doi.org/10.1186/s12886-015-0088-xCrossRefPubMedPubMedCentral

72.

Smeeth L, Fletcher AE (2002) Improving the response rates to questionnaires. BMJ 324:1168–1169. https://doi.org/10.1136/bmj.324.7347.1168CrossRefPubMedPubMedCentral

73.

Nakash RA, Hutton JL, Jorstad-Stein EC, Gates S, Lamb SE (2006) Maximising response to postal questionnaires–a systematic review of randomised trials in health research. BMC Med Res Methodol 6:5. https://doi.org/10.1186/1471-2288-6-5CrossRefPubMedPubMedCentral

74.

Teresi JA (2006) Different approaches to differential item functioning in health applications. Advantages, disadvantages and some neglected topics. Med Care 44:S152-170. https://doi.org/10.1097/01.mlr.0000245142.74628.abCrossRefPubMed

75.

Owsley C, McGwin G Jr (2004) Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults. Ophthalmology 111:2259–2264. https://doi.org/10.1016/j.ophtha.2004.06.026CrossRefPubMed

Title: Quality of life in glaucoma
Authors: Kareem Latif
Takashi Nishida
Sasan Moghimi
Robert N. Weinreb
Publication date: 05-04-2023
Publisher: Springer Berlin Heidelberg
Keyword: Glaucoma
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 10/2023
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-023-06050-z

At a glance: The STEP trials

Springer Medicine

Quality of life in glaucoma

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 10/2023

Influence of isofocal intraocular lenses on objective refraction based on autorefraction and aberrometry

Factors associated with severe corneal endothelial damage following acute primary angle closure in Chinese subjects

Network meta-analysis comparing efficacy and safety of different protocols of corneal cross-linking for the treatment of progressive keratoconus

Topical antibiotic prophylaxis before intravitreal injections: a pilot study

Current clinical applications of anterior segment optical coherence tomography angiography: a review

PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety